Dr Alison Birtle is a consultant clinical oncologist and Honorary senior lecturer specialising in the treatment of urological cancers. Her MD thesis was in PSA negative prostate cancers at the institute of Urology.
She is advisor to Macmillan on patient information for prostate, bladder and testicular tumours, Trustee and medical advisor to Fight Bladder cancer, and Secretary to the British Uro Oncology Group.
She has published widely and lectures nationally and internationally.
Alison has been Clinical research Lead for Lancashire and South Cumbria cancer Research network, and more recently, Associate Clinical Lead for cancer Research and since March 2018, Speciality Group Lead for cancer research for North West Coast CRN>
She is a former member of the prostate CSG and stepped down as chair of the Bladder/renal NIHR Clinical study group in 2018 after two terms. She remains a member of the advanced bladder cancer subgroup.
Dr Birtle has been principal investigator and chief investigator on numerous urological clinical trials, and is the Chief Investigator on the POUT trial.
In 2018, she was awarded one of the national 70 stars of the NHS award by NSH England and the NHS Confederations part of the NHS 70 anniversary.
She was also awarded NWCCRN Research Practitioner of the Year in 2018, and more locally runner up in Lancashire doctor of the year.
She is passionate about patient access to clinical trials and believes in the mantra of a trial for every patient.
Dr Birtle combines full time NHS work with a passion for research, and for musical theatre